NVDA
52
-5
GD
41
-4
SYF
86
-6
NEE
54
7
GOOGL
48
-5
AN
50
-5
ACN
47
-5
BA
47
2
CMG
66
-4
AME
74
-4
NAVI
52
-2
XYL
35
-2
JNPR
50
-6
OMC
50
-16
TEL
60
-8
SLG
57
-3
CFG
74
2
MLM
45
-5
AIV
64
4
IBM
47
-3
NVDA
52
-5
GD
41
-4
SYF
86
-6
NEE
54
7
GOOGL
48
-5
AN
50
-5
ACN
47
-5
BA
47
2
CMG
66
-4
AME
74
-4
NAVI
52
-2
XYL
35
-2
JNPR
50
-6
OMC
50
-16
TEL
60
-8
SLG
57
-3
CFG
74
2
MLM
45
-5
AIV
64
4
IBM
47
-3
Financhill
Back

Bpost SA de Droit Public Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
34

BPOSF
Bpost SA de Droit Public

Last Price:
5.06
Seasonality Move:
-0.16%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
34
Bpost SA de Droit Public (BPOSF) is a Sell

Is Bpost SA de Droit Public a Buy, Sell or Hold?

  • The current Bpost SA de Droit Public [BPOSF] share price is $5.06. The Score for BPOSF is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • BPOSF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPOSF Stock Price Chart

What is Bpost SA de Droit Public's stock price today?

  • The Bpost SA de Droit Public share price today is $5.06
    The current trend is relatively stagnant and BPOSF is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

BPOSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 0 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.06 - 5.06) Sell
Bollinger Bands (100): (5.06 - 5.06) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

BPOSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.06 Sell
20-day SMA: 5.06 Sell
50-day SMA: 5.06 Sell
200-day SMA: 5.06 Sell
8-day EMA: 5.06 Sell
20-day EMA: 5.06 Sell
50-day EMA: 5.08 Sell
200-day EMA: 7.11 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Bpost SA de Droit Public Earnings Growth & BPOSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Bpost SA de Droit Public Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):